4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001123292-09-000577
Director sold 149,208 shares at an average $4.08 ($608,228)
From the SEC's structured data for this filing
Trades in this filing
Lowe David George · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2009-06-08 | Sale : show line 1 in the form | −65,708 | $4.21 | $276,388 | 469,500 | I |
| 2009-06-09 | Sale : show line 2 in the form | −47,500 | $3.99 | $189,392 | 422,000 | I |
| 2009-06-10 | Sale : show line 3 in the form | −36,000 | $3.96 | $142,448 | 386,000 | I |
| Open-market sales · 149,208 sh · avg $4.08 · $608,228 | ||||||
Loading xslF345X03/edgar.xml…